Heron Therapeutics, Inc. (HRTX) ownership: Top institutional holder: Rubric Capital Management LP ($24.04M). Insider activity: Net Seller (0 buys, 20 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Rubric Capital Management LP | 30046828.00 | $24.04M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11185325.00 | $14.54M | 2025-12-31 |
| BlackRock Fund Advisors | 1019962.00 | $13.36M | 2016-12-31 |
| VANGUARD GROUP INC | 9820384.00 | $12.77M | 2025-12-31 |
| Point72 Asset Management, L.P. | 4775877.00 | $10.51M | 2025-03-31 |
| Clearline Capital LP | 12235239.00 | $9.79M | 2026-03-31 |
| BlackRock, Inc. | 10106422.00 | $8.09M | 2026-03-31 |
| ORBIMED ADVISORS LLC | 9816940.00 | $7.85M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-06 | |
| Sell | null | 2026-06-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 |
Back to HRTX overview · HRTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.